Manufacturing

Manufacturing2020-10-02T00:04:21+00:00

CAR-T cell Manufacturing

BIOMEDICINE AND GENETICS on COH Campus
  • COH is one of the leaders in  chimeric antigen receptor (CAR) T cell therapy in the US
  • COH have one of the most comprehensive CAR T cell programs in the world, with 15 CAR T clinical trials ongoing and plans to open numerous additional trials in the coming year, including for patients with multiple myeloma, prostate cancer, liver cancer and breast cancer
  • City of Hope, with its clinical care, research and production facilities all on one campus, is uniquely positioned to lead this work. Few institutions are capable of harnessing the same comprehensive “bench to bedside” resources necessary for the discovery, translational research, clinical development, manufacturing, quality assurance and delivery of leading-edge treatments for our patients. City of Hope has the ability to harvest, reprogram, multiply and deliver T cells all on the same campus